" class="no-js "lang="en-US"> Denis Zeyer - Medtech Alert
Saturday, August 02, 2025
Denis Zeyer

Denis Zeyer

About Denis Zeyer

NovAliX a client-centric organization providing expert driven innovative outsourcing and insourcing research services for drug discovery. Core expertize includes synthetic organic chemistry expertise, FBDD and SBDD. The comprehensive portfolio of biophysical and analytical technologies include: chemical microarray SPR, native MS, NMR, Biacore, ITC as well as strong structural biology expertise based on x-ray crystallography and electron microscopy.

Related Story

NovAliX Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries

November 30 2021

NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces its […]